Recurrent Breast Cancer Completed Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006228Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast CancerTreatment